EverHint – Aggressive Momentum – Top 3 Signals for Jun 24, 2026
Excerpt: 3 signals. Healthcare leads (2). price range $40-$747. 2 with insider selling.
What This Signal Is
Triple threat: high momentum + high volume + high volatility. Maximum momentum with high risk/reward. For aggressive traders seeking the strongest momentum setups.
Entry Criteria:
- High RSI momentum
- High volume surge
- High volatility
- Minimum ADV: $25M+
- Earnings buffer: 7 days
Holding period: 1-4 weeks | Risk level: High
Market Context
The major indices are showing a mixed but broadly cautious tone heading into the session. The S&P 500 and Nasdaq are both posting modest declines, with tech-heavy names applying the most drag, while the Dow's slight outperformance suggests investors are rotating toward more defensive or value-oriented positions. This kind of divergence is a meaningful backdrop for momentum swing strategies — it signals that broad market conviction is limited, meaning individual setups need to demonstrate strong relative strength to stand out from the noise.
Volatility, as measured by the VIX at 19.51, sits in a moderate zone — elevated enough to produce meaningful intraday price swings that momentum strategies can exploit, but not so high as to introduce excessive whipsaw risk. This is generally a constructive environment for swing signals, as price moves tend to have enough follow-through to be actionable without the erratic reversals that come with VIX readings above 25. Traders should remain attentive to position sizing, however, as even moderate volatility can compress risk-reward ratios if entries are poorly timed.
The emergence of Healthcare as the top sector for today's signals aligns well with the broader rotation dynamic visible in the index performance. When growth and tech leadership fades, capital tends to flow into defensive sectors like Healthcare, which offer more predictable earnings profiles and lower sensitivity to rate or macro concerns. For momentum swing setups in this environment, Healthcare's relative strength provides a more stable directional bias, reducing the likelihood of signals being undermined by sudden sector-wide reversals.
📊 Signals (3 of 3 total)
Ranked by composite momentum score
| # | Ticker | Company | Sector | Price | Score | Insider | MCap |
|---|---|---|---|---|---|---|---|
| 1 | NTRA | Natera, Inc. | Healthcare | $259.97 | 1.00 | -$13,269,617 | $37.2B |
| 2 | IESC | IES Holdings, Inc. | Industrials | $747.49 | 0.50 | — | $14.9B |
| 3 | CNTA | Centessa Pharmaceutica... | Healthcare | $40.50 | 0.00 | -$836,142 | $6.3B |
Field Notes
Sector concentration: Healthcare (2), Industrials (1)
Insider selling: NTRA (Natera, Inc., -$13,269,617), CNTA (Centessa Pharmaceuticals plc, -$836,142)
Data coverage: 66.7% insider, 0.0% congressional, 0.0% earnings, 33.3% news
Peer Analysis
CNTA (Centessa Pharmaceuticals plc): Leads 5 peers: APGE ($132.69), XENE ($55.58), AAPG ($17.08), RARE ($29.11), CELC ($96.38)
NTRA (Natera, Inc.): Leads 5 peers: MTD ($1203.18), WAT ($369.18), BNTX ($90.21), DGX ($203.11), TEVA ($34.22)
IESC (IES Holdings, Inc.): Leads 5 peers: PRIM ($92.69), DY ($483.48), FLR ($53.17), TTEK ($28.58), AWI ($157.70)
Recent Headlines
CNTA (Centessa Pharmaceuticals plc)
- Acquisition of Centessa by Lilly Approved by the High Court of Justice of England and Wales
Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.
This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/
📢 Support the project by liking, sharing, or subscribing — it helps more readers discover these signals.